Suppr超能文献

用于测定甲状旁腺激素的氨基末端放射免疫测定法的临床适用性。

Clinical applicability of an amino-terminal radioimmunoassay for determination of parathyroid hormone.

作者信息

Mollerup C L, Bruun E, Hesselfeldt-Nielsen J, Hummer L

机构信息

Department of Endocrine Surgery, Rigshospitalet, Copenhagen, Denmark.

出版信息

Acta Chir Scand. 1988 Jul-Aug;154(7-8):419-23.

PMID:3188789
Abstract

With a radioimmunoassay using hPTH 1-34 for antibody production, for radioiodination and as a standard, hPTH 1-34 was detectable (detection limit 40 pg/ml) preoperatively in peripheral blood in 14 of 29 patients with hyperparathyroidism, but in no controls. In all patients with parathyroid adenoma and detectable hPTH 1-34 preoperatively, the values fell after parathyroid surgery. Contrastingly, three of four patients with diffuse parathyroid hyperplasia and two of three with normal parathyroid glands showed a rise in hPTH 1-34 postoperatively, which was concomitant with very low serum calcium levels. In studies of hPTH 1-34 in central venous blood (3 patients), levels were detectable in all samples, but not in simultaneously drawn peripheral blood. Values for hPTh 1-34 in central blood correlated to PTH determined from a bovine assay, but the peripheral samples showed no correlation. The low levels of circulating N-terminal immunoreactivity in peripheral blood make this assay inapplicable for routine diagnostic purposes. These low levels are due not only to low secretion rates, but also to rapid peripheral metabolization.

摘要

采用用人甲状旁腺激素1 - 34进行抗体生产、放射性碘化及作为标准品的放射免疫测定法,在29例甲状旁腺功能亢进患者中,有14例术前在外周血中可检测到甲状旁腺激素1 - 34(检测限为40 pg/ml),而对照组中均未检测到。在所有术前可检测到甲状旁腺激素1 - 34的甲状旁腺腺瘤患者中,甲状旁腺手术后该值下降。相反,4例弥漫性甲状旁腺增生患者中有3例以及3例甲状旁腺正常患者中有2例术后甲状旁腺激素1 - 34升高,这与极低的血清钙水平同时出现。在对3例患者中心静脉血中甲状旁腺激素1 - 34的研究中,所有样本均可检测到该水平,但同时采集的外周血中未检测到。中心血中甲状旁腺激素1 - 34的值与用牛检测法测定的甲状旁腺激素相关,但外周样本无相关性。外周血中循环N端免疫反应性水平较低,使得该检测不适用于常规诊断目的。这些低水平不仅归因于低分泌率,还归因于外周的快速代谢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验